Zhuo-ming Li
State Key Laboratory of Clean Energy UtilizationZhejiang University(CN)
Publications by Year
Research Areas
Traditional Chinese Medicine Analysis, Traditional Chinese Medicine Studies, PARP inhibition in cancer therapy, Phosphodiesterase function and regulation, Nitric Oxide and Endothelin Effects
Most-Cited Works
- → Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics(2018)538 cited
- → Validation of Phosphodiesterase-10 as a Novel Target for Pulmonary Arterial Hypertension via Highly Selective and Subnanomolar Inhibitors(2019)52 cited
- → Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1(2014)43 cited
- → mTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt/GSK-3β/C/EBPα signaling pathway(2018)39 cited
- → Downregulation of adipose triglyceride lipase promotes cardiomyocyte hypertrophy by triggering the accumulation of ceramides(2014)33 cited
- → Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives(2020)33 cited
- → AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy(2014)31 cited
- → C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling(2017)26 cited
- → Upregulation of heme oxygenase-1 potentiates EDH-type relaxations in the mesenteric artery of the spontaneously hypertensive rat(2013)25 cited
- → PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy(2018)24 cited